The Amvia family enables physiological pacing and workflow optimization to help physicians deliver exceptional patient-centric care with less effort.
May 12, 2023
Biotronic Receives CE Approval for the World’s First Pacemaker and CRT-P Family Approved for Left Bundle Branch Pacing
May 12, 2023 — Biotronik, a leading global medical technology company with 60 years of experience in developing trusted…
Read More
Along with this latest IDE approval for the treatment of Small Vessel indication, Concept Medical received two other IDE approvals for the Magic Touch SCB family of products for the treatment of coronary In-Stent Restenosis (ISR) indication and Below-the-Knee indication (PTA)
May 12, 2023
Concept Medical's Receives FDA Approval for the MagicTouch-Sirolimus Coated Balloon
May 12, 2023 — The US FDA has granted an Investigational Device Exemption (IDE) approval for Concept Medical Inc’s…
Read More
A heart muscle cell with mutations in the gene that makes the Rotatin protein (bottom) has disorganized muscle fibers (red) compared to healthy heart muscle cell (top).
May 11, 2023
Research Identifies New Cause of Heart Failure Condition in Children
May 11, 2023 — In an effort to determine the cause behind a rare condition that causes heart failure in children,…
Read More
On this occasion, it unveiled MyLab Omega eXP, a new portable ultrasound system featuring advanced cardio tools and AI-powered automation and showcased Suitestensa CVIS, an all-in-one cardiovascular management solution for enterprises, and Caas Qardia, a cutting-edge echocardiography software platform
May 11, 2023
The Esaote Group Unveiled MyLab Omega eXP at EACVI2023
May 11, 2023 — Esaote, a leading manufacturers of medical diagnostic systems (specifically, ultrasound, dedicated MRI…
Read More
May 11, 2023
Under 40s with Mental Health Problems Have Elevated Risks of Heart Attack and Stroke
May 11, 2023 — Adults in their 20s and 30s with mental disorders have an up to three-fold elevated likelihood of a…
Read More
The randomized controlled double-blind trial evaluated the effect of hyperbaric oxygen therapy (HBOT) on the cardiac function of long COVID patients
May 10, 2023
Oxygen Therapy Improves Heart Function in Patients with Long COVID
May 10, 2023 — A small randomized trial in patients with post-COVID syndromehas found that hyperbaric oxygen therapy…
Read More
This research-use-only offering supports the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases
May 10, 2023
Women are Underrepresented in Cardiovascular Clinical Trials
May 10, 2023 — A new study has shown that women are underrepresented in late-breaking cardiovascular clinical trials (…
Read More
The AIMed Global Summit will be held June 4-7, 2023, at the San Diego Convention Center, featuring a comprehensive agenda of key leaders and wide-ranging sessions on artificial intelligence (AI), its application, opportunities and implications on healthcare.
By Christine Book
May 10, 2023
AiMed Global Summit 2023 to Focus on “Changing Healthcare One Connection at a Time” in San Diego
May 10, 2023 — The AiMed Global Summit will be held June 4-7, 2023, in San Diego, Calif, and program details offered…
Read More
INSPIRIS RESILIA aortic valve
May 09, 2023
Edwards' Aortic Valve with Resilia Tissue Shows Favorable Durability, Safety and Efficacy Outcomes in 7-year Data
May 9, 2023 — Edwards Lifesciences announced new data from the COMMENCE aortic trial, demonstrating low rates of…
Read More
Heart Test Laboratories, Inc. d/b/a HeartSciences, an artificial intelligence (AI)-based medical technology company focused on transforming ECGs/EKGs to save lives through the early detection of heart disease, announces completion of patient enrollment for its MyoVista wavECG pivotal study for FDA De Novo submission.
May 09, 2023
HeartSciences Announces Completion of Patient Enrollment for FDA Pivotal Study of MyoVista wavECG
May 9, 2023 — Heart Test Laboratories, Inc. d/b/a HeartSciences, an artificial intelligence (AI)-based medical…
Read More
Acarix, a leader in acoustic and AI-based cardiac diagnostics, announced today, in collaboration with the American College of Cardiology (ACC), a first edition of a framework for the CADScor System.
May 09, 2023
Acarix and the American College of Cardiology Collaborate on First Edition Framework for CADScor System
May 9, 2023 — Acarix, a leader in acoustic and AI-based cardiac diagnostics, announced today, in collaboration with the…
Read More
Marshall-Plan study presented in a late breaking science session today at EHRA 2023
May 08, 2023
Novel Ablation Strategy Improves Freedom from Arrhythmias in Atrial Fibrillation Patients
May 8, 2023 — An innovative three-step ablation approach including ethanol infusion of the vein of Marshall improves…
Read More
This recent advance fulfils the requirements needed to promote an efficient translation of innovations and new treatments from the bench to the bedside in this field
May 08, 2023
New Reproducible and Minimally Invasive Stroke Model Through an Endovascular Approach
May 8, 2023 — Researchers of the Cellular and Molecular Neurobiology (CMN) Research Group at the Germans Trias i Pujol…
Read More
Ucardia, a cardiac conditioning software developer, announced today that it has reached an agreement to acquire Phas3
May 08, 2023
Ucardia Announces Acquisition of PHAS3; Launches Cardiologist Practice Remote Patient Monitoring Offering
May 8, 2023 — Ucardia, a cardiac conditioning software developer, announced today that it has reached an agreement to…
Read More
72-year-old with intermediate (50-70%) stenosis in distal right coronary artery, who underwent coronary CTA due to atypical chest pain.
May 05, 2023
Rapid Onsite FFR-CT Algorithm Helps Facilitates Clinical Adoption
May 5, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR), a…
Read More
A new book written by and for interventional cardiologists provides a collection of detailed case studies, clinical data and imagery, according to Cedars-Sinai, whose team from Smidt Heart Institute is among the editors of the publication.
Christine Book
May 04, 2023
Book Offering Collection of Complex Interventional Cardiology Cases Published by Team from Cedars-Sinai Smidt Heart Institute
May 4, 2023 — A new book on a broad collection of cases, led by a team of investigators from the Smidt Heart Institute…
Read More
By Mohammad Sahebjalal, MD
May 04, 2023
Radiation Scatter 101: Risks, Dangers and Latest Solutions
 Invented in 1896 by Enrico Salvioni, the fluoroscope remains a flagship technology of modern medicine. The live video…
Read More
This study evaluates SELUTION SLR in the treatment of occlusive disease of the superficial femoral artery (SFA) and proximal popliteal artery (PPA) and has been designed to support FDA approval
May 04, 2023
MedAlliance Enrolls First US Patient into its Third FDA IDE Study: SFA SELUTION4SFA
May 4, 2023 — The first US patient has been enrolled in the SELUTION4SFA Sirolimus DEB study by Dr. Arthur Lee at the…
Read More
Investigators are one step closer to achieving this breakthrough in preventive healthcare and offering patients personalized predictions of their heart health thanks to a novel deep-learning tool and artificial intelligence (AI) algorithm developed at Cedars-Sinai.
May 04, 2023
New AI Tool Developed at Cedars-Sinai Can Predict Adverse Cardiac Events Like Heart Attacks, and Show How Risk Changes Over Time
May 4, 2023 — What if you could predict if-or when-your patient might experience a heart attack, cardiac arrest or…
Read More
Transaction values Avertix at an enterprise value of $195 million
May 04, 2023
Avertix, Maker of First and Only FDA-Approved Implantable Heart Attack Warning System, to Become Publicly Traded via Merger with BIOS Acquisition Corporation
May 4, 2023 — Avertix Medical, Inc., formerly known as Angel Medical Systems, Inc., a company focused on improving long…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now